Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Life Healthcare Group ( (HK:0928) ) just unveiled an announcement.
King International Investment Limited has provided additional disclosure regarding the appointment of Mr. Wang as an executive director and co-chairman of the board, clarifying that he is president, director and controlling shareholder of U.S.-listed Yubo International Biotech Limited, and that he briefly served as an executive director of Easy Smart Group Holdings Limited in 2025. The supplemental announcement confirms that, apart from these roles, Mr. Wang has not held directorships in other listed companies over the past three years and that all other details of his appointment remain unchanged, offering investors more transparency on the governance and leadership profile of the Hong Kong–listed group.
More about Life Healthcare Group
King International Investment Limited is an investment holding company incorporated in the Cayman Islands and listed in Hong Kong. Through its subsidiaries, the Group engages in diversified investment activities, and its board comprises both executive and independent non-executive directors, reflecting a typical governance structure for mid-cap Hong Kong–listed investment firms.
Average Trading Volume: 1,753,036
Technical Sentiment Signal: Hold
Current Market Cap: HK$168.4M
For an in-depth examination of 0928 stock, go to TipRanks’ Overview page.